Impact of concomitant proton pump inhibitors in patients treated for advanced or metastatic NSCLC: a target trial emulation protocol.
- DOI
- 10.1016/j.esmorw.2026.100751
- Published
- 2026 Sep
- Container
- ESMO real world data and digital oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.esmorw.2026.100751,
title = {Impact of concomitant proton pump inhibitors in patients treated for advanced or metastatic NSCLC: a target trial emulation protocol.},
author = {Le Borgne F and De Montfort A and Guego B and Martin E and Guerin C and Bosquet L and Bocquet F and Robain M and Raoul JL and Pérol D},
year = {2026},
journal = {ESMO real world data and digital oncology},
doi = {10.1016/j.esmorw.2026.100751},
url = {https://doi.org/10.1016/j.esmorw.2026.100751}
}RIS
TY - JOUR TI - Impact of concomitant proton pump inhibitors in patients treated for advanced or metastatic NSCLC: a target trial emulation protocol. AU - Le Borgne F AU - De Montfort A AU - Guego B AU - Martin E AU - Guerin C AU - Bosquet L AU - Bocquet F AU - Robain M AU - Raoul JL AU - Pérol D PY - 2026 JO - ESMO real world data and digital oncology DO - 10.1016/j.esmorw.2026.100751 UR - https://doi.org/10.1016/j.esmorw.2026.100751 ER -
APA
F, L. B., A, D. M., B, G., E, M., C, G., L, B., F, B., M, R., JL, R., & D, P. (2026). Impact of concomitant proton pump inhibitors in patients treated for advanced or metastatic NSCLC: a target trial emulation protocol.. ESMO real world data and digital oncology. https://doi.org/10.1016/j.esmorw.2026.100751
Source records
- pubmed · retrieved 2026-09-26T20:36:56.942Z